144 related articles for article (PubMed ID: 12689408)
1. Roundtable report: importance of antiretroviral drug concentrations in sanctuary sites and viral reservoirs.
Reddy YS; Kashuba A; Gerber J; Miller V;
AIDS Res Hum Retroviruses; 2003 Mar; 19(3):167-76. PubMed ID: 12689408
[No Abstract] [Full Text] [Related]
2. Hidden HIV reservoirs: will eradication of the virus be possible?
Gomez E
Newsline People AIDS Coalit N Y; 1998 Mar; ():18-9. PubMed ID: 11367451
[TBL] [Abstract][Full Text] [Related]
3. What can we do to reduce the viral reservoir in HIV-1-infected individuals?
Pohlmeyer CW; Walker-Sperling VE; Blankson JN
Future Microbiol; 2016 Jul; 11():839-42. PubMed ID: 27416850
[No Abstract] [Full Text] [Related]
4. Emergence of raltegravir-resistant HIV-1 in the central nervous system.
Watanabe K; Honda M; Watanabe T; Tsukada K; Teruya K; Kikuchi Y; Oka S; Gatanaga H
Int J STD AIDS; 2010 Dec; 21(12):840-1. PubMed ID: 21297097
[TBL] [Abstract][Full Text] [Related]
5. Sanctuary sites in HIV-1 infection.
Hoetelmans RM
Antivir Ther; 1998; 3 Suppl 4():13-7. PubMed ID: 10723504
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated neurocognitive disorders and central nervous system drug penetration: what next?
Marra CM
Antivir Ther; 2015; 20(4):365-7. PubMed ID: 25781980
[TBL] [Abstract][Full Text] [Related]
7. HIV pharmacology: barriers to the eradication of HIV from the CNS.
McGee B; Smith N; Aweeka F
HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170
[TBL] [Abstract][Full Text] [Related]
8. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
9. [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].
Marcello A; Giacca M
Pathologica; 2000 Aug; 92(4):291-3. PubMed ID: 11029891
[No Abstract] [Full Text] [Related]
10. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy.
Schrager LK; D'Souza MP
JAMA; 1998 Jul; 280(1):67-71. PubMed ID: 9660366
[TBL] [Abstract][Full Text] [Related]
11. Latency and reservoirs for HIV-1.
Siliciano RF
AIDS; 1999; 13 Suppl A():S49-58. PubMed ID: 10885762
[No Abstract] [Full Text] [Related]
12. Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.
Guihot A; Tubiana R; Breton G; Marcelin AG; Samri A; Assoumou L; Goncalves E; Bricaire F; Costagliola D; Calvez V; Rouzioux C; Autran B; Katlama C; Carcelain G; ;
AIDS; 2010 Feb; 24(4):614-7. PubMed ID: 19952710
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 dynamics in vivo: implications for therapy.
Simon V; Ho DD
Nat Rev Microbiol; 2003 Dec; 1(3):181-90. PubMed ID: 15035022
[TBL] [Abstract][Full Text] [Related]
14. Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy.
Saksena NK; Potter SJ
AIDS Rev; 2003; 5(1):3-18. PubMed ID: 12875103
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment of central nervous system HIV-1 infection: a review.
Gisslén M; Hagberg L
HIV Med; 2001 Apr; 2(2):97-104. PubMed ID: 11737386
[TBL] [Abstract][Full Text] [Related]
16. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
[No Abstract] [Full Text] [Related]
17. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication.
Crowe SM; Sonza S
J Leukoc Biol; 2000 Sep; 68(3):345-50. PubMed ID: 10985250
[TBL] [Abstract][Full Text] [Related]
18. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.
Pomerantz RJ
Clin Infect Dis; 2002 Jan; 34(1):91-7. PubMed ID: 11731950
[TBL] [Abstract][Full Text] [Related]
19. The challenge of viral reservoirs in HIV-1 infection.
Blankson JN; Persaud D; Siliciano RF
Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
[TBL] [Abstract][Full Text] [Related]
20. Genital shedding of HIV-1 despite successful antiretroviral therapy.
Vernazza PL
Lancet; 2001 Nov; 358(9293):1564. PubMed ID: 11716875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
